Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01 AI127828, 75N93019C00074, R01 AI127828, U19-AI110483, P01-AI125180-01, R37-AI049660, P01-AI125180-01, 1R01AI121252, 1U01AI141993)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32-HL116271-07)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01-AG054991)
United States Department of Defense | Defense Advanced Research Projects Agency (HR001117S0019)
Received: 19 June 2020
Accepted: 16 September 2020
First Online: 7 October 2020
: F.E.-H.L. is the founder of MicroB-plex and has research grants with Genentech. W.T.H. has consulted for ViveBio, AARP and Biogen; has received research support from Fujirebio; and has a patent on CSF-based diagnosis of FTLD-TDP. M.S.D. is a consultant for Inbios, Vir Biotechnology and NGM Biopharmaceuticals and is on the scientific advisory board of Moderna. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology and Emergent BioSolutions. J.E.C. has served as a consultant for Pfizer, Novavax, Lilly and Luna Biologics; is a member of the scientific advisory boards of CompuVax and Meissa Vaccines; and is Founder of IDBiologics. The Crowe laboratory at Vanderbilt University Medical Center has received unrelated funding support in sponsored research agreements from Moderna, Sanofi-Aventis and IDBiologics.
Free to read: This content has been made available to all.